Literature DB >> 33490232

Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer.

Khushbukhat Khan1, Sadia Safi1, Asma Abbas1, Yasmin Badshah1, Erum Dilshad2, Mehak Rafiq3, Kainat Zahra1, Maria Shabbir1.   

Abstract

Breast cancer is the most prevailing disease among women. It actually develops from breast tissue and has heterogeneous and complex nature that constitutes multiple tumor quiddities. These features are associated with different histological forms, distinctive biological characteristics, and clinical patterns. The predisposition of breast cancer has been attributed to a number of genetic factors, associated with the worst outcomes. Unfortunately, their behavior with relevance to clinical significance remained poorly understood. So, there is a need to further explore the nature of the disease at the transcriptome level. The focus of this study was to explore the influence of Krüppel-like factor 3 (KLF3), tumor protein D52 (TPD52), microRNA 124 (miR-124), and protein kinase C epsilon (PKCε) expression on breast cancer. Moreover, this study was also aimed at predicting the tertiary structure of KLF3 protein. Expression of genes was analyzed through real-time PCR using the delta cycle threshold method, and statistical significance was calculated by two-way ANOVA in Graphpad Prism. For the construction of a 3D model, various bioinformatics software programs, Swiss Model and UCSF Chimera, were employed. The expression of KLF3, miR-124, and PKCε genes was decreased (fold change: 0.076443, 0.06969, and 0.011597, respectively). However, there was 2-fold increased expression of TPD52 with p value < 0.001 relative to control. Tertiary structure of KLF3 exhibited 80.72% structure conservation with its template KLF4 and was 95.06% structurally favored by a Ramachandran plot. These genes might be predictors of stage, metastasis, receptor, and treatment status and used as new biomarkers for breast cancer diagnosis. However, extensive investigations at the tissue level and in in vivo are required to further strengthen their role as a potential biomarker for prognosis of breast cancer.
Copyright © 2020 Khushbukhat Khan et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33490232      PMCID: PMC7803292          DOI: 10.1155/2020/1354381

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  52 in total

Review 1.  Analyzing protein-protein interaction networks.

Authors:  Gavin C K W Koh; Pablo Porras; Bruno Aranda; Henning Hermjakob; Sandra E Orchard
Journal:  J Proteome Res       Date:  2012-03-02       Impact factor: 4.466

Review 2.  The mammalian zinc finger transcription factor Krüppel-like factor 3 (KLF3/BKLF).

Authors:  Richard C M Pearson; Alister P W Funnell; Merlin Crossley
Journal:  IUBMB Life       Date:  2011-02-24       Impact factor: 3.885

3.  Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

Authors:  Nadine Tung; Nancy U Lin; John Kidd; Brian A Allen; Nanda Singh; Richard J Wenstrup; Anne-Renee Hartman; Eric P Winer; Judy E Garber
Journal:  J Clin Oncol       Date:  2016-03-14       Impact factor: 44.544

4.  Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.

Authors:  Mark A Rubin; Sooryanarayana Varambally; Rameen Beroukhim; Scott A Tomlins; Daniel R Rhodes; Pamela L Paris; Matthias D Hofer; Martina Storz-Schweizer; Rainer Kuefer; Jonathan A Fletcher; Bae-Li Hsi; Jennifier A Byrne; Kenneth J Pienta; Colin Collins; William R Sellers; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

Review 5.  Malignant granular cell tumor of the breast.

Authors:  R Chetty; M R Kalan
Journal:  J Surg Oncol       Date:  1992-02       Impact factor: 3.454

6.  Loss of epigenetic Kruppel-like factor 4 histone deacetylase (KLF-4-HDAC)-mediated transcriptional suppression is crucial in increasing vascular endothelial growth factor (VEGF) expression in breast cancer.

Authors:  Alpana Ray; Mohamed Alalem; Bimal K Ray
Journal:  J Biol Chem       Date:  2013-08-06       Impact factor: 5.157

7.  miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma.

Authors:  Jun Wei; Fei Wang; Ling-Yuan Kong; Shuo Xu; Tiffany Doucette; Sherise D Ferguson; Yuhui Yang; Kayla McEnery; Krishan Jethwa; Olsi Gjyshi; Wei Qiao; Nicholas B Levine; Frederick F Lang; Ganesh Rao; Gregory N Fuller; George A Calin; Amy B Heimberger
Journal:  Cancer Res       Date:  2013-05-01       Impact factor: 12.701

8.  PKCε Is Required for KRAS-Driven Lung Tumorigenesis.

Authors:  Rachana Garg; Mariana Cooke; Fernando Benavides; Martín C Abba; Michelle Cicchini; David M Feldser; Marcelo G Kazanietz
Journal:  Cancer Res       Date:  2020-09-29       Impact factor: 12.701

9.  Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.

Authors:  Heidi Lyng; Runar S Brøvig; Debbie H Svendsrud; Ruth Holm; Olav Kaalhus; Kjetil Knutstad; Halldis Oksefjell; Kolbein Sundfør; Gunnar B Kristensen; Trond Stokke
Journal:  BMC Genomics       Date:  2006-10-20       Impact factor: 3.969

Review 10.  Protein kinase C epsilon: an oncogene and emerging tumor biomarker.

Authors:  Michael A Gorin; Quintin Pan
Journal:  Mol Cancer       Date:  2009-02-19       Impact factor: 27.401

View more
  3 in total

1.  Determining KLF14 tertiary structure and diagnostic significance in brain cancer progression.

Authors:  Kainat Zahra; Maria Shabbir; Yasmin Badshah; Janeen H Trembley; Zunaira Badar; Khushbukhat Khan; Tayyaba Afsar; Ali Almajwal; Nawaf W Alruwaili; Suhail Razak
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

2.  Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.

Authors:  Hong-Jian Shan; Wen-Xiang Gu; Gang Duan; Hong-Liang Chen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 3.  Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management.

Authors:  Sadia Hassan; Adeeb Shehzad; Shahid Ali Khan; Waheed Miran; Salman Khan; Young-Sup Lee
Journal:  Biomedicines       Date:  2022-08-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.